Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent (vol 8, 2017)

doi:10.1038/s41467-018-05501-0

GSTDTAP > 资源环境科学

DOI	10.1038/s41467-018-05501-0
	Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent (vol 8, 2017)
	Wang, Pengju 1; Li, Xiaozhu 2; Wang, Jiwei 1; Gao, Dongling 1; Li, Yuenan 1; Li, Haoze 1; Chu, Yongchao 1; Zhang, Zhongxian 1; Liu, Hongtao 1; Jiang, Guozhong 1; Cheng, Zhenguo 1; Wang, Shengdian 2; Dong, Jianzeng 3; Feng, Baisui 1,4; Chard, Louisa S.5; Lemoine, Nicholas R.1,5; Wang, Yaohe 1,5
	2018-01-10
发表期刊	NATURE COMMUNICATIONS
ISSN	2041-1723
出版年	2018
卷号	9
文章类型	Correction
语种	英语
国家	Peoples R China; England
领域	资源环境
收录类别	SCI-E
WOS记录号	WOS:000419677600001
WOS类目	Multidisciplinary Sciences
WOS研究方向	Science & Technology - Other Topics
URL	查看原文
引用统计
文献类型	期刊论文
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/203909
专题	资源环境科学
作者单位	1.Zhengzhou Univ, Sinobritish Res Ctr Mol Oncol, Natl Ctr Int Res Cell & Gene Therapy, Sch Basic Med Sci,Acad Med Sci, Zhengzhou 450052, Henan, Peoples R China; 2.Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China; 3.Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China; 4.Zhengzhou Univ, Affiliated Hosp 2, Sect Digest Dis, Zhengzhou 450014, Henan, Peoples R China; 5.Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, London EC1M 6BQ, England
推荐引用方式 GB/T 7714	Wang, Pengju,Li, Xiaozhu,Wang, Jiwei,et al. Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent (vol 8, 2017)[J]. NATURE COMMUNICATIONS,2018,9.
APA	Wang, Pengju.,Li, Xiaozhu.,Wang, Jiwei.,Gao, Dongling.,Li, Yuenan.,...&Wang, Yaohe.(2018).Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent (vol 8, 2017).NATURE COMMUNICATIONS,9.
MLA	Wang, Pengju,et al."Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent (vol 8, 2017)".NATURE COMMUNICATIONS 9(2018).